Astellas Pharma (ALPMY) Q3 2024 Earnings

1AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.12
-0.03
0.07
0.17

Details

Expected EPS
0.05939311836
Actual EPS
0.130452
Surprise EPS
0.07
Surprise Percent
+119.64%

Description

Astellas Pharma (ALPMY) has reported earnings of 0.130452 per share for Q3 2024.

0 Comments

Share your thoughts